TEST.V - FluroTech Ltd.
| Previous Close | 0.0750 |
| Open | 0.0850 |
| Bid | 0.0800 x 0 |
| Ask | 0.0850 x 0 |
| Day's Range | 0.0750 - 0.0850 |
| 52 Week Range | 0.0600 - 0.3750 |
| Volume | 41,000 |
| Avg. Volume | 28,520 |
| Market Cap | 4.071M |
| Beta (5Y Monthly) | -0.47 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0820 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
FluroTech Announces a New US Distributor
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), a technology company focused on becoming the standard in the analytical cannabis testing market, is pleased to announce it has entered into an non-exclusive US distribution agreement with US based Mabre Corporation (“Mabre”). The distribution agreement provides for FluroTech and Mabre to work together to introduce the CompleTestTM to a client list of approximately 26,000 potential customers. “We believe it presents an important opportunity for us,” Said Rex Kary, COO of FluroTech “We have been focused on hemp compliance for a while now and we believe that this partnership with Mabre will introduce FluroTech to a lot more organizations that we believe our product can benefit.”
- GlobeNewswire
FluroTech Provides an Update on the COVID-19 Test Development Thesis
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), is pleased to provide an update on its business strategy as it relates to the development of a COVID-19 analytical testing device. Development of a novel methodology that can be applied to rapidly detect, identify, and test new future viruses and associated antibodies with a low-cost, point of care kit.
- GlobeNewswire
FluroTech Partners With Albany Medical College For the Potential Development of a COVID-19 Diagnostic Test
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) is pleased to announce that it has entered into a strategic Agreement in Principle with Alberta BioPhotonics Inc. (“ABP”) and Albany Medical College (“AMC”) to form FluroTest LLC (“FluroTest”). The collaboration will have primary focus on adapting FluroTech’s CompleTest™ platform technology to test for a range of viruses including COVID-19, as well as accurately determining viral load. Additionally, FluroTest believes its technology can also be adapted to allow for the detection of specific anti-SARS-CoV-2 human antibodies in blood samples, potentially confirming the development of immunity.
- GlobeNewswire
FLUROTECH ANNOUNCES A NEW EASTERN US FOCUSED DISTRIBUTOR
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), a technology company focused on becoming the standard in the analytical Cannabis and Hemp testing market, is pleased to announce it has entered into an non-exclusive US distribution agreement with North Carolina based HempLab Inc. The distribution agreement provides for FluroTech and HempLab to work together to introduce the CompleTestTM to regulatory bodies and law enforcement agencies on the east coast of the United States with the goal of having CompleteTestTM become an approved testing device to accurately determine if a sample of biomass contains more than 0.3% THC, the legal limit to be classified as Hemp under the USDA guidelines. HempLab’s Chief Executive Officer and Co-Founder John Herring, brings over 25 years of experience in law enforcement and a keen understanding of how new technology can help alleviate compliance testing, including the ability to identify the difference between Hemp and Marijuana, which is an issue currently backlogging the cannabis industry.
- GlobeNewswire
FLUROTECH ANNOUNCES CHANGES TO NON-EXCLUSIVE DISTRIBUTOR AGREEMENT IN THE US AND NEW TECHNOLOGICAL ADVANCES
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), a technology company focused on becoming the standard in the analytical cannabis and hemp testing market, announces that it has agreed to release CaryLand LLC from the non-exclusive distribution agreement (“Agreement”) that was announced on December 10, 2019. FluroTech still believes that the ever-evolving Federal Drug Administration regulations represent an exceptional opportunity for the CompleTest™ to be utilized by growers and regulators to distinguish hemp from marijuana. FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis and hemp industries.
- GlobeNewswire
FLUROTECH ANNOUNCES NORMAL COURSE ISSUER BID
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) announces that the TSX Venture Exchange (the “Exchange”) has accepted its Notice of Intention (the “Notice”) to make a normal course issuer bid (“NCIB”) to purchase outstanding common shares (“Shares”) of FluroTech Ltd. (the “Corporation”) through open market transactions through the facilities of the Exchange. The Corporation is authorized to purchase up to 1,800,000 Shares under the NCIB, representing approximately 3.3% of the issued and outstanding Shares.
- ACCESSWIRE
FluroTech to Present at MjMicro Virtual Investor Conference hosted by MjInvest.com
LOS ANGELES, CA / ACCESSWIRE / January 27, 2020 / MjLink.com Inc. a wholly owned subsidiary of Social Life Network, Inc. (OTCQB: WDLF ), is pleased to announce FluroTech Ltd. (OTCQB:FLURF)(TSX:TEST), as ...
- Simply Wall St.
Introducing FluroTech (CVE:TEST), The Stock That Slid 65% In The Last Year
The nature of investing is that you win some, and you lose some. Anyone who held FluroTech Ltd. (CVE:TEST) over the...
- GlobeNewswire
FluroTech Announces Non-Exclusive Distribution Agreement in the US
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), a technology company focused on becoming the standard in the analytical cannabis and hemp testing market, is pleased to announce a distribution agreement with CaryLand, LLC based in Boulder, Colorado. CaryLand provides mobile and laboratory based testing technologies and consulting solutions to the agriculture, cannabis and hemp industries.
- GlobeNewswire
FluroTech Wins the People’s Choice Award at 2019 Startup Calgary
This is the second award in 2019 bestowed on FluroTech for its technology and entrepreneurship, the first being the Best Technology at the 2019 Lift conference in Vancouver. “It was an honor to be acknowledged among a field of 15 entrepreneurial focused companies,” stated Danny Dalla-Longa Chief Executive Officer. FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry.
- GlobeNewswire
FluroTech Announces September and Q3 2019 Revenue
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”), a technology company focused on the analytical cannabis and hemp testing market, is pleased to announce five unit sales which generated revenue of $116,548 in September, the end of FluroTech’s third quarter of 2019. With the commercialization of the CompleTestTM, the Company continues to ramp up sales efforts through expansion of the sales team, ongoing negotiations with distributors in the United States, and the launch of a referral program with industry participants possessing demonstrated national and international reach. Currently, FluroTech’s sales and marketing team is validating the cadmium testing protocol designed by the scientific development team and are preparing for its introduction to the market.
- GlobeNewswire
StartUp Calgary Selects FluroTech as One of This Year’s Top Startups
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”), a technology company focused on the analytical cannabis and hemp testing market, is pleased to announce it has been selected as one of the top 15 up and coming startups of the year by StartUp Calgary. As a result of its selection FluroTech will have a booth at the 10th Annual Launch Party at The Big Four in Stampede Park in Calgary on Tuesday, November 12 from 6:00 PM to 9:00 PM. Anyone interested in learning more about FluroTech or any of the other great Calgary startups are encouraged to join the evening’s festivities. “We appreciate the community nominations and the recognition by StartUp Calgary of our efforts.
- GlobeNewswire
Flurotech Receives Research License From Health Canada
FluroTech Ltd.(TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”), a technology company focused on the analytical cannabis and hemp testing market, has been awarded a Research License from Health Canada. The license permits the Company to grow up to 144 cannabis plants from seed or clone and store up to 1 KG at its laboratory and cannabis research facility for use in the development of testing protocols for cannabinoids, heavy metals and other contaminants. Furthermore, the research license will allow for future development projects around pesticide and mold testing applications.
- GlobeNewswire
FluroTech to Present at Upcoming MjMicro Conference in Beverley Hills
FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”), an aspiring leader in analytical cannabis and hemp testing technologies, is pleased to be one of the featured presenters at the upcoming MjMicro conference in Beverley Hills, California. The conference, which will be held on October 16 at the Sofitel Hotel, is an invitational forum that unites publicly traded and emerging growth private cannabis companies led by seasoned executives with high net-worth investors and financial analysts. FluroTech CEO, Danny Dalla Longa, will host a featured presentation to update investors and analysts on recent company milestones.
- GlobeNewswire
FluroTech Provides Biotracker Update and Proposes Unique Solution to Ascertain Legal From Illicit Vape Cartridges
FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), an aspiring leader in analytical cannabis and hemp testing technologies, announces that, in order to test the performance of its biotracker technology outside of the laboratory, company scientists introduced the technology to numerous hemp plants in its outdoor beta testing sites. The plants from the beta testing sites have now been harvested and FluroTech is pleased to announce that initial results appear to show that the harvested plants’ root systems did take up the biotrackers and dispersed throughout the plant. The Company is excited by these initial preliminary results and believes that its biotracker technology, once it is ready for commercialization, has the potential to address several issues facing the cannabis industry today, provided that it continues to perform as currently anticipated by the Company. For example, such technology may be applied to specifically label extract in vape cartridges to allow government officials and intermediaries along the supply chain to identify legally produced vape cartridges from those produced illegally.
- GlobeNewswire
FluroTech Exhibits at the Grow Up Conference & Expo
FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”), an aspiring leader in analytical cannabis and hemp testing technologies, is pleased to be exhibiting at the Grow Up Conference & Expo this Thursday to Saturday at the Scotiabank Convention Center in Niagara Falls, Ontario, Canada. The Grow Up Conference and Expo is focused on the education, collaboration and growth of the cannabis growing industry. FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry.
- GlobeNewswire
FluroTech Provides Update on Hemp Betas
In Canada, a limited number of strains of hemp are available to growers and these strains usually contain CBDA at or below 4.5%. This has resulted in robust demand for a testing device that can quantify low concentrations of CBDA. The hemp growers working with the Company have planted several different strains and have been benchmarking the plants based on their CBDA concentrations.
- Simply Wall St.
Investors Who Bought FluroTech (CVE:TEST) Shares A Year Ago Are Now Down 12%
Investors can approximate the average market return by buying an index fund. But if you buy individual stocks, you can...
